OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Immunopathology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Micro-to multi-chimerism: the multiple facets of a singular phenomenon	224
Learning cell identity in immunology, neuroscience, and cancer	174
Vascular galectins in tumor angiogenesis and cancer immunity	159
Adaptive immunity, chronic inflammation and the clock	135
Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16	108
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors	75
The microbiome’s hidden influence: preclinical insights into inflammatory responses in necrotizing enterocolitis	64
Role of polyamines in intestinal mucosal barrier function	62
Regulatory T lymphocytes as a therapy for ischemic stroke	59
Genetics and functional genomics of multiple sclerosis	54
Diseases of blood vessels: Immune system involvement in vasculitis and vasculopathy	49
Correction to: Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation	48
Immune checkpoint for pregnancy	47
Correction: Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	47
Regenerating the uterus: translational advances in endometrial bioengineering and immunotherapeutics	47
Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation	46
Thromboinflammatory challenges in stroke pathophysiology	45
Genetics of rheumatoid arthritis	43
Publisher Correction: Epithelial recognition and elimination against aberrant cells	40
The role of vaccines in the COVID-19 pandemic: what have we learned?	40
Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation	39
Immunization of preterm infants: current evidence and future strategies to individualized approaches	37
Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus	37
The role of microglia in early neurodevelopment and the effects of maternal immune activation	36
The duality of microchimerism and cancer in parous women: a review and evolutionary perspective	36

Towards multiomic analysis of oral mucosal pathologies	35
Tolerance and autoimmunity in the liver	34
Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries	34
Single-cell RNA-seq methods to interrogate virus-host interactions	33
Dyslipidemia and female reproductive failures: perspectives on lipid metabolism and endometrial immune dysregulation	33
TNF in the liver: targeting a central player in inflammation	33
CAF-immune cell crosstalk and its impact in immunotherapy	32
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy	32
Revisiting transplant immunology through the lens of single-cell technologies	31
Correction to: MAIT cells in liver inflammation and fibrosis	31
Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection	31
The aging immune system in Alzheimer’s and Parkinson’s diseases	30
Unveiling the immunopathology of stroke: a comprehensive view on brain-immune interaction	29
CAR T-cell behavior and function revealed by real-time imaging	29
Beyond defence: Immune architects of ovarian health and disease	28
Arginine metabolism in myeloid cells in health and disease	27
Local anesthetics and immunotherapy: a novel combination to fight cancer	27
Immune compartments at the brain’s borders in health and neurovascular diseases	24
Tissue-resident immunity in the female and male reproductive tract	24
Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers	24
Circadian regulation of innate immunity in animals and humans and implications for human disease	24
Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition	24
Mothers and mosquitoes: climate change contributes to the spread of vector-borne pathogens posing a substantial threat to pregnant women	24
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment	23
B cells in autoimmune hepatitis: bystanders or central players?	23
Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2)	23
Correction to: Complement in ischaemia–reperfusion injury and transplantation	22
How genetic risk contributes to autoimmune liver disease	22
Role of alarmins in poststroke inflammation and neuronal repair	21
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy	21
Correction to: Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target	21
Gut microbiota-derived metabolites tune host homeostasis fate	21
Role of glia and extracellular matrix in controlling neuroplasticity in the central nervous system	20
Harnessing the liver to induce antigen-specific immune tolerance	20
Intertwining roles of circadian and metabolic regulation of the innate immune response	20
Maternal and placental galectins: key players in the feto-maternal symbiotic tango	19
Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease	19
Proteomics to study cancer immunity and improve treatment	18
Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells	18
Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke	18
Tumor microenvironment antigens	17
Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers	17
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology	17
Intracellular galectin interactions in health and disease	16
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells	16
Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	15
The sweet and the bitter sides of galectin-1 in immunity: its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells	15
The role of circulating cell-free DNA as an inflammatory mediator after stroke	15
Cell therapies for viral diseases: a new frontier	15
Physiological and immunological barriers in the lung	14

Mechanisms of vascular damage in ANCA vasculitis	14
The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation	14
IgE and non-IgE-mediated pathways in anaphylaxis	13
Heterogeneity of tissue-resident immunity across organs and in health and disease	13
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment	12
A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma	12
Microbiota-dependent modulation of intestinal anti-inflammatory CD4+ T cell responses	12
Establishment of tissue-resident immune populations in the fetus	12
Role of Hyaluronic acid and its chemical derivatives in immunity during homeostasis, cancer and tissue regeneration	12
Lessons (to be) learned from liquid biopsies: assessment of circulating cells and cell-free DNA in cancer and pregnancy-acquired microchimerism	12